PharmaTalkRadio

In this podcast from the 2018 Mobile in Clinical Trials conference, Dr Paul Glimcher, Julius Silver Professor of Neural Science and Physiology at NYU alongside Dr Daniel Karlin, CEO at Healthmode presented on the future of mobile data in clinical trials.

Drs Glimcher and Karlin discussed this rapidly evolving space with an emphasis on the barriers and opportunities in the mobile health arena. More specifically:

• What are the Barriers to gathering an incorporating Mobile data into clinical trials?

• What are the most important new datatypes that are evolving in the Mobile Health space?

• How can we use Real World Measurements to identify new classes of clinically relevant endpoints to go beyond Billing Codes?

• Can we expect to see large-scale Mobile databases for synthetic use on the model of EMRs and ICD codes?

• How should we think of these new classes of data, are they just novel bioindicators or something else?

Dr Karlin is returning to Mobile 2019 as co-chair.

Speakers: Paul Glimcher, PhD, Julius Silver Professor of Neural Science and Physiology, NYU

                  Daniel Karlin, MD, CEO, Healthmode

In this podcast from the 2018 Mobile in Clinical Trials conference, Eli Lilly's Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, reported on incorporating a variety of mobile devices – including a smart phone, smart insulin pens, connected devices, mifi, and laptops, into a clinical trial.

Considerations and lessons learned for:

• Connecting all the devices

• Implementation differences between traditional vs siteless

• Coordinating the equipment; challenges and successes

• Lessons learned

• What’s next?

Speaker: Joseph Kim, Sr Advisor, Clinical Operations and Digital Registry, Digital Health Office | Translational Technology & Innovation, Eli Lilly & Co

In this podcast from Mobile in Clinical Trials 2018, Pfizer's Project Team Lead, Early Clinical Development, Digital Medicine, Dr Carrie Northcott speaks about considerations and lessons learned from the validation, verification and use of digital wearable technology in a Atopic Dermatitis Clinical Trial and some of Pfizer's forward-leaning work in decision making around novel digital endpoints. 

Dr Northcott is coming back to Mobile 2019 to share results and next steps on this trial. 

Speakers: Carrie Northcott, PhD, Project Team Lead, Early Clinical Development, Digital Medicine, Pfizer, Inc

In this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include:

What Merck is doing in digital health and AIExternal collaborations on AISmart trial initiative to enable patient-centric studies

Kai Bode is returning to Mobile 2019 to share an update on Merck's digital strategy 2.0 and how they are engineering for scale.

Speakers: Jyoti Shah, Associate Director, Data Development MRL IT, Merck & Co, Inc

                   Kai Bode, Director, Digital and Analytics Technology, Merck & Co, Inc

In this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease and Multiple Sclerosis. Session takeaways include:

Understand what Digital Biomarker innovation means for the future of clinical development and potentially personalized healthcare.Be inspired to use mobile sensors technology in the context of clinical trials and beyond.Develop a detailed understanding of the underlying complexity to run such efforts and be able to plan for it.Understand how regulators are looking at these novel approaches.

Speaker:

Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)

The 9th annual DPharm conference with take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

This is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process.

Speaker:

Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine

The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

This 4 minute podcast summarizes what you can expect at the 6th annual Mobile in Clinical Trials conference. This event provides sessions on the latest progress in applying mobile applications and patient-facing technologies to connect and empower patients, while obtaining better outcomes in drug development.

The conference takes place September 16, 2019 at the Renaissance Boston Waterfront Hotel, Boston, MA. The program is co-chaired by Bayer’s Michelle Shogren, Director of Innovation, Pharma R&D Clinical Operations and Healthmode’s Dr. Dan Karlin, CEO. For more information please visit www.theconferenceforum.org or contact us at [email protected]

An Insight into Our Possible Future Faster than You Think

This keynote session was presented at the 2018 DPharm conference. Estonia is now a digital republic with a virtual government, blockchained and secure. Our keynote guest from Estonia tells us how Estonia became the fastest country in the world to go digital. Its 1.3 million citizens pay with their mobile phones, have their health records stored in the digital cloud, and filed their annual tax return online in five minutes. This session demonstrates how Estonian citizens have come to own their personal health records, how doctors have to get their permission to use these records, and how patients choose their own medications digitally. We also learn about their challenges, policies, and of course their vision for digital clinical trials.

Speakers:

Indrek Onnik, Program Manager, E-Estonia Showroom, a partner of the Estonian Government

The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

In this session presented at the 2018 DPharm conference, Rob Goodwin and Amy Nordo share an exciting new collaboration - including industry and academia, as well as health authorities and leading technologists - positioned to break through the barriers to allow the power and the promise of eSource across companies and medical centers.

The potential for eSource has been discussed for years, but realizing its promise has been difficult. While most health data today can be captured within electronic health records, the diversity of systems across medical centers and around the world coupled with a lack of health data interoperability has limited our ability to source clinical trial data from existing electronic systems across thousands of investigator sites supporting trials globally.

Speakers:

Rob Goodwin, VP, Operations Center of Excellence, Global Product Development, Pfizer, Inc.

Amy Nordo, Program Director, Duke Center for Healthcare Informatics

The 9th annual DPharm conference will take place September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

In this podcast from DPharm 2018, Pfizer's VP of Clinical Supply Chain, Michael Ku, speaks about some of Pfizer's earliest work making blockchain real as well as some of their forward-leaning work digitizing supply chain for clinical trials.

The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.